IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 256 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $198,944 | -21.1% | 43,724 | +22.1% | 0.01% | -22.2% |
| Q2 2023 | $252,166 | +8.7% | 35,819 | -5.7% | 0.01% | -10.0% |
| Q1 2023 | $231,966 | +29.3% | 37,965 | +35.2% | 0.01% | +11.1% |
| Q4 2022 | $179,470 | -99.9% | 28,086 | +1.5% | 0.01% | -30.8% |
| Q3 2022 | $265,136,000 | +86545.8% | 27,676 | 0.0% | 0.01% | -7.1% |
| Q2 2022 | $306,000 | -34.1% | 27,676 | -0.7% | 0.01% | -22.2% |
| Q1 2022 | $464,000 | -2.7% | 27,882 | +11.6% | 0.02% | +12.5% |
| Q4 2021 | $477,000 | -12.3% | 24,989 | +13.3% | 0.02% | -20.0% |
| Q3 2021 | $544,000 | -13.1% | 22,062 | -8.3% | 0.02% | -9.1% |
| Q2 2021 | $626,000 | +203.9% | 24,072 | +270.5% | 0.02% | +175.0% |
| Q1 2021 | $206,000 | – | 6,497 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |